ORCHPHARMA
Invest with MTF
Invest Now
Invest in Orchid Pharma with 2.21X leverage
Orchid Pharma live price: ₹506.2. It opened at ₹512 vs previous close ₹512; intraday high/low: ₹514/₹501. The 50 & 200 DMA stand at ₹652.33/₹771.25.
Orchid Pharma Performance
- Low
- ₹501
- High
- ₹514
- 52 Week Low
- ₹489
- 52 Week High
- ₹899
- Open Price₹512
- Previous Close₹512
- Volume89,652
- 50 DMA₹652.33
- 100 DMA₹702.11
- 200 DMA₹771.25
Investment Returns
- Over 1 Month -23.82%
- Over 3 Month -38.4%
- Over 6 Month -28.62%
- Over 1 Year -35.93%
Smart Investing Starts Here Start SIP with Orchid Pharma for Steady Growth!
Orchid Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 136.1
- PEG Ratio
- -1.6
- Market Cap Cr
- 2,567
- P/B Ratio
- 2
- Average True Range
- 28.74
- EPS
- 5.12
- Dividend Yield
- 0
- MACD Signal
- -41.82
- RSI
- 25.33
- MFI
- 22.92
Orchid Pharma Financials
Orchid Pharma Technicals
EMA & SMA
Current Price
₹506.20
-5.9
(-1.15%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹584.47
- 50 Day
- ₹652.33
- 100 Day
- ₹702.11
- 200 Day
- ₹771.25
Resistance and Support
522.37
- R3 575.73
- R2 561.37
- R1 536.73
- S1 497.73
- S2 483.37
- S3 458.73
Orchid Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-11 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-12 | Quarterly Results |
Orchid Pharma F&O
About Orchid Pharma
- NSE Symbol
- ORCHPHARMA
- BSE Symbol
- 524372
- Managing Director
- Mr. Manish Dhanuka
- ISIN
- INE191A01027
Similar Stocks to Orchid Pharma
Orchid Pharma FAQs
Orchid Pharma share price is ₹506 As on 16 March, 2026 | 12:11
The Market Cap of Orchid Pharma is ₹2567.4 Cr As on 16 March, 2026 | 12:11
The P/E ratio of Orchid Pharma is 136.1 As on 16 March, 2026 | 12:11
The PB ratio of Orchid Pharma is 2 As on 16 March, 2026 | 12:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.